Originally developed at Monash University as part of research into the lipolytic domain of hGH, AOD-9604 retains many of the fat-mobilising characteristics of full-length growth hormone while lacking the broader growth-promoting and insulin-resistance effects associated with the parent molecule
While 80% of the market currently uses subcutaneous injection, the oral segment is projected to grow at the fastest rate through 2030
Until recently, patients could only access Wegovy through a private prescriber, like ourselves
While endogenous GLP-1 has a short half-life and limited ability to act on distant organs, exogenous GLP-1R agonists have proven highly effective in reducing food intake and promoting weight loss
Clinical trials demonstrate that gradual escalation produces superior long-term weight loss and adherence compared to rapid dose jumps
215,216 By reinstating proper epigenetic control, GLP-1 RAs could potentially slow down the aging process and mitigate age-related cellular dysfunction, particularly in individuals with diabetes